NCT01632254

Brief Summary

The aim of this study is to develop non-invasive MRI, and MRS approaches that will quantify the plaque composition and lipid content of plaques and will have the potential for repeated in vivo measurements. To investigate sensitivity and specificity of 3.0 Tesla MRI and MRS for dimension and composition assessment of carotid artery plaques, in particularly those plaques with lipid rich necrotic cores. This non-invasive cross-sectional study, compares carotid parameters of in-vivo 3.0 Tesla MRI, MRS and B-mode ultrasound with histology specimens collected at endarterectomy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2009

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

October 13, 2011

Completed
9 months until next milestone

First Posted

Study publicly available on registry

July 2, 2012

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
Last Updated

July 20, 2012

Status Verified

May 1, 2012

Enrollment Period

5.9 years

First QC Date

October 13, 2011

Last Update Submit

July 19, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • Plaque characteristics as assessed by 3.0 Tesla MRI.

    Total plaque volume, plaque calcification volume, plaque haemorrhage volume, lipid rich necrotic core volume, fibrous cap thickness, as assessed by 3.0 Tesla MRI

    1 month

Secondary Outcomes (2)

  • Water and lipid content of the plaque as assessed by MRS/3.0T MRI

    1 month

  • Plaque composition and size as assessed by histological analysis

    1 month

Study Arms (1)

Patients with ≥70% carotid artery stenosis

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with ≥70% carotid artery stenosis on clinical ultrasound duplex examination, scheduled for endarterectomy in the Athero-Express study.

You may qualify if:

  • These patients are eligible to undergo carotid endarterectomy in either the St. Antonius Hospital, Nieuwegein.
  • Willing and able to undergo non-invasive MRI, MRS and ultrasound examinations in the Academic Hospital Center, Amsterdam.
  • Signed informed consent

You may not qualify if:

  • Patients not suitable for MRI (e.g. metal in the body, as a result of pacemaker or artificial cardiac valves); claustrophobia; surgery performed in the neck area of the carotid measurements.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Academic Medical Center

Amsterdam, 1105AZ, Netherlands

RECRUITING

Related Links

MeSH Terms

Conditions

Atherosclerosis

Condition Hierarchy (Ancestors)

ArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Erik Stroes, MD PhD

CONTACT

Diederik van Wijk, MD

CONTACT

Study Design

Study Type
observational
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD PhD

Study Record Dates

First Submitted

October 13, 2011

First Posted

July 2, 2012

Study Start

July 1, 2009

Primary Completion

June 1, 2015

Study Completion

June 1, 2015

Last Updated

July 20, 2012

Record last verified: 2012-05

Locations